Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proton therapy versus conventional radiotherapy for the treatment of cavernous sinus benign meningioma, a randomized controlled phase III study protocol (COG-PROTON-01).
Lesueur P, Clarisse B, Lequesne J, Licaj I, Feuvret L, Stefan D, Ricard D, Noel G, Balosso J, Lange M, Capel A, Durand-Zaleski I, Castera M, Legrand B, Goliot N, Hedou C, Grellard JM, Valable S. Lesueur P, et al. BMC Cancer. 2024 Dec 30;24(1):1594. doi: 10.1186/s12885-024-13353-9. BMC Cancer. 2024. PMID: 39736544 Free PMC article.
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol.
Lesueur P, Lequesne J, Grellard JM, Dugué A, Coquan E, Brachet PE, Geffrelot J, Kao W, Emery E, Berro DH, Castera L, Goardon N, Lacroix J, Lange M, Capel A, Leconte A, Andre B, Léger A, Lelaidier A, Clarisse B, Stefan D. Lesueur P, et al. BMC Cancer. 2019 Mar 4;19(1):198. doi: 10.1186/s12885-019-5413-y. BMC Cancer. 2019. PMID: 30832617 Free PMC article.
Proton therapy for adult-type diffuse glioma: A systematic review.
Goliot N, Mohssine S, Stefan D, Leclerc A, Emery E, Riverain J, Missohou F, Geffrelot J, Kao W, Valable S, Balosso J, Lesueur P. Goliot N, et al. Among authors: lesueur p. Crit Rev Oncol Hematol. 2024 Dec;204:104501. doi: 10.1016/j.critrevonc.2024.104501. Epub 2024 Sep 7. Crit Rev Oncol Hematol. 2024. PMID: 39251047 Review.
[Why proton therapy? And how?].
Thariat J, Habrand JL, Lesueur P, Chaikh A, Kammerer E, Lecomte D, Batalla A, Balosso J, Tessonnier T. Thariat J, et al. Among authors: lesueur p. Bull Cancer. 2018 Mar;105(3):315-326. doi: 10.1016/j.bulcan.2017.12.004. Bull Cancer. 2018. PMID: 29422248 Review. French.
[New indications of protontherapy for adults intracranial tumours].
Lesueur P, Doyen J, Lecornu M, Calugaru V, Florescu C, Missohou F, Geffrelot J, Mammar H, Stefan D, Feuvret L, Balosso J. Lesueur P, et al. Cancer Radiother. 2021 Oct;25(6-7):545-549. doi: 10.1016/j.canrad.2021.06.009. Epub 2021 Jun 24. Cancer Radiother. 2021. PMID: 34175224 French.
Hadrontherapy Interactions in Molecular and Cellular Biology.
Thariat J, Valable S, Laurent C, Haghdoost S, Pérès EA, Bernaudin M, Sichel F, Lesueur P, Césaire M, Petit E, Ferré AE, Saintigny Y, Skog S, Tudor M, Gérard M, Thureau S, Habrand JL, Balosso J, Chevalier F. Thariat J, et al. Among authors: lesueur p. Int J Mol Sci. 2019 Dec 24;21(1):133. doi: 10.3390/ijms21010133. Int J Mol Sci. 2019. PMID: 31878191 Free PMC article. Review.
41 results